Category: Blog
Biomarker-Driven Research: Transforming Treatments for Rare Cancers Reassessing the classification of rare cancer types Historically, research on rare cancers centered around tumor Read Now 
Reflections from ESMO 2025 Progress, Breakthrough Science and the Future of Oncology We were delighted to attend the recent Read Now 
Transform Relationship Management into a Strategic Advantage Leveraging Our Core Culture In the dynamic world of clinical trials and data management, success Read Now 
Harnessing R Shiny Dashboards for Statistical Programming and Data Visualization In today’s data-driven environment, biotech and pharmaceutical companies increasingly require tools that can transform raw Read Now 
AI, Open Source, and the Future of Biostatistics Reflections on innovation and change in statistical programming Artificial intelligence (AI), the ascendance of open-source Read Now 
Audit Trails, AI, and the Human Heartbeat Key Takeaways from SCDM 2025 The 2025 Society for Clinical Data Management (SCDM) Conference was Read Now 
Tackling Special Characters with SAS and R Clean data, confident results In clinical research, ensuring the highest standard of data quality is Read Now 
The Resurgence of Antibody-drug Conjugates How ADCs are redefining cancer therapy Cancer treatment is undergoing a transformation, fueled by advances Read Now 
Precision Medicine The Rise of Targeted Cancer Therapies New cancer cases are expected to increase globally from Read Now 
Highlights from Clinical Trials in Oncology East Coast 2025 From Protocol Design to Partnerships Earlier this month, I had the privilege of chairing the Clinical Read Now